Publications by authors named "Benjamin C Lane"

Claim this Profile
B
Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial.
Wendy S Lane, Stephen L Weinrib, Michael J Lawrence, Benjamin C Lane, Ryan T Jarrett

Endocr Pract· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin analogs with reduced systemic exposure.
Rolf Wagner, Karl W Mollison, Luping Liu, Cynthia L Henry, Teresa A Rosenberg, Benjamin C Lane

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, Marie Osterland, Jiahong Wang, Benjamin C Lane

J Pharmacol Exp Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
Philip R Kym, Michael E Kort, Michael J Coghlan, Jimmie L Moore, Rui Tang, Benjamin C Lane

J Med Chem· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis